| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.8 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |